Literature DB >> 10942233

Participation of granulocyte colony-stimulating factor in the growth regulation of leukemia cells from Philadelphia chromosome-positive acute leukemia and blast crisis of chronic myeloid leukemia.

T Inukai1, K Sugita, K Mitsui, K Iijima, K Goi, T Tezuka, S Kojika, K Kagami, T Mori, A Kinoshita, T Suzuki, T Okazaki-Koyama, S Nakazawa.   

Abstract

Granulocyte colony-stimulating factor (G-CSF) has been shown to support the growth of multipotential hematopoietic stem cells in addition to the cells of neutrophilic lineage. Philadelphia chromosome (Ph1)-positive leukemia has its origin in the hematopoietic stem cell. In the present study, we demonstrated that the proliferation of leukemic cells from chronic myeloid leukemia in blast crisis (CML-BC) and Ph1-positive acute lymphoblastic leukemia (ALL) cases is frequently stimulated with G-CSF in vitro. We next studied a total of 12 leukemic cell lines established from CML-BC (n= 6) and Ph1-positive acute leukemia (n= 6): four 'myeloid', five 'biphenotypic', and three 'lymphoid' types. All cell lines expressed G-CSF receptor (G-CSFR) in flow cytometric analysis, but their proliferative response to G-CSF in 3H-thymidine incorporation assay varied. The 'biphenotypic' cell lines expressed G-CSFR at higher levels and showed the most pronounced response to G-CSF. The 'lymphoid' cell lines showed intermediate G-CSFR expression with the modest response to G-CSF. Unexpectedly, 'myeloid' cell lines showed lower G-CSFR expression and lower G-CSF response compared with 'biphenotypic' cell lines. In three of four 'myeloid' cell lines, proliferation was partially inhibited by an addition of anti-G-CSF neutralizing monoclonal antibody into culture medium. Further, the % inhibition of 3H-thymidine uptake of cell lines positively correlated with the amount of their intracellular G-CSF measured by enzyme immunoassay, suggesting an autocrine growth mechanism via the G-CSF/G-CSFR interaction. These results suggest that G-CSF play an important role in the growth regulation of leukemia cells from Ph1-positive acute leukemia and CML-BC.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10942233     DOI: 10.1038/sj.leu.2401837

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  5 in total

Review 1.  CREB and leukemogenesis.

Authors:  Er-Chieh Cho; Bryan Mitton; Kathleen M Sakamoto
Journal:  Crit Rev Oncog       Date:  2011

2.  Glucocorticoid-induced granzyme A expression can be used as a marker of glucocorticoid sensitivity for acute lymphoblastic leukemia therapy.

Authors:  Akira Myoumoto; Kaoru Nakatani; Taka-Aki Koshimizu; Hiroshi Matsubara; Souichi Adachi; Gozoh Tsujimoto
Journal:  J Hum Genet       Date:  2007-02-20       Impact factor: 3.172

3.  CREB in the pathophysiology of cancer: implications for targeting transcription factors for cancer therapy.

Authors:  Kathleen M Sakamoto; David A Frank
Journal:  Clin Cancer Res       Date:  2009-04-07       Impact factor: 12.531

4.  A novel, polymer-coated oncolytic measles virus overcomes immune suppression and induces robust antitumor activity.

Authors:  Kaname Nosaki; Katsuyuki Hamada; Yuto Takashima; Miyako Sagara; Yumiko Matsumura; Shohei Miyamoto; Yasuki Hijikata; Toshihiko Okazaki; Yoichi Nakanishi; Kenzaburo Tani
Journal:  Mol Ther Oncolytics       Date:  2016-11-02       Impact factor: 7.200

5.  A Case of Therapy-Related Acute Leukemia With Mixed Phenotype With BCR-ABL1 After Treatment of Diffuse Large B-Cell Lymphoma.

Authors:  Dahae Yang; Sung Ran Cho; Seri Jung; Woonhyoung Lee; Hyun Yong Hwang; Ho Seop Lee; Yang Soo Kim; Jong Rak Choi; Mi Hyang Kim
Journal:  Ann Lab Med       Date:  2017-03       Impact factor: 3.464

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.